The American Journal of Medicine
Volume 118, Issue 3 , Pages 292-300 , March 2005

Routine human immunodeficiency virus testing: An economic evaluation of current guidelines

  • Rochelle P. Walensky, MD, MPH

      Affiliations

    • Divisions of Infectious Disease and General Medicine, Department of Medicine, Massachusetts General Hospital, and the Partners AIDS Research Center, Harvard Medical School, Boston, Massachusetts
    • Division of Infectious Disease, Brigham and Women’s Hospital, Boston, Massachusetts
    • Corresponding Author InformationRequests for reprints should be addressed to Rochelle P. Walensky, MD, MPH, Division of General Medicine, Massachusetts General Hospital, 50 Staniford Street, 9th Floor, Boston, Massachusetts 02114.
    • ,
  • Milton C. Weinstein, PhD

      Affiliations

    • Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
    • ,
  • April D. Kimmel

      Affiliations

    • Divisions of Infectious Disease and General Medicine, Department of Medicine, Massachusetts General Hospital, and the Partners AIDS Research Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • George R. Seage III, ScD, MPH

      Affiliations

    • Department of Health Policy and Management, Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts
    • ,
  • Elena Losina, PhD

      Affiliations

    • Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts
    • ,
  • Paul E. Sax, MD

      Affiliations

    • Division of Infectious Disease, Brigham and Women’s Hospital, Boston, Massachusetts
    • ,
  • Hong Zhang, SM

      Affiliations

    • Divisions of Infectious Disease and General Medicine, Department of Medicine, Massachusetts General Hospital, and the Partners AIDS Research Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Heather E. Smith

      Affiliations

    • Divisions of Infectious Disease and General Medicine, Department of Medicine, Massachusetts General Hospital, and the Partners AIDS Research Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Kenneth A. Freedberg, MD, MSc

      Affiliations

    • Divisions of Infectious Disease and General Medicine, Department of Medicine, Massachusetts General Hospital, and the Partners AIDS Research Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • A. David Paltiel, PhD

      Affiliations

    • Yale School of Medicine, New Haven, Connecticut.

Received 24 November 2003 ,Accepted 11 July 2004.

References 

  1. Fleming PL , Wortley PM , Karon JM , DeCock KM , Janssen RS . Tracking the HIV epidemic (current issues, future challenges) . Am J Public Health. . 2000;90:1037–1041
  2. CDC . Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings . MMWR Recomm Rep. . 1993;42:1–6
  3. CDC . Revised guidelines for HIV counseling, testing, and referral . MMWR Recomm Rep. . 2001;50:1–57
  4. Janssen RS , St Louis ME , Satten GA , et al.   HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group . N Engl J Med. . 1992;327:445–452
  5. St Louis ME , Rauch KJ , Petersen LR , Anderson JE , Schable CA , Dondero TJ  The Sentinel Hospital Surveillance Group . Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States . N Engl J Med. . 1990;323:213–218
  6. Goggin MA , Davidson AJ , Cantril SV , O’Keefe LK , Douglas JM . The extent of undiagnosed HIV infection among emergency department patients (results of a blinded seroprevalence survey and a pilot HIV testing program) . J Emerg Med. . 2000;19:13–19
  7. Rhee KJ , Albertson TE , Kizer KW , Burns MJ , Hughes MJ , Ascher MS . A comparison of HIV-1, HBV, and HTLV-I/II seroprevalence rates of injured patients admitted through California emergency departments . Ann Emerg Med. . 1992;21:397–401
  8. Walensky RP , Losina E , Steger-Craven KA , Freedberg KA . Identifying undiagnosed human immunodeficiency virus (the yield of routine, voluntary inpatient testing) . Arch Intern Med. . 2002;162:887–892
  9. Pincus JM , Crosby SS , Losina E , King ER , LaBelle C , Freedberg KA . Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center . Clin Infect Dis. . 2003;37:1699–1704
  10. del Rio C , Paredas CF , Duffus W , et al.   Routinely recommended HIV testing at an urban urgent-care clinic—Atlanta, Georgia, 2000 . MMWR Morb Mortal Wkly Rep. . 2001;50:538–541
  11. Kelen GD , Shahan JB , Quinn TC . Emergency department-based HIV screening and counseling (experience with rapid and standard serologic testing) . Ann Emerg Med. . 1999;33:147–155
  12. Glick NR , Silva A , Zun L , Whitman S . HIV testing in a resource-poor urban emergency department . AIDS Educ Prev. . 2004;16:126–136
  13. Irwin KL , Valdiserri RO , Holmberg SD . The acceptability of voluntary HIV antibody testing in the United States (a decade of lessons learned) . AIDS. . 1996;10:1707–1717
  14. Freedberg KA , Losina E , Weinstein MC , et al.   The cost effectiveness of combination antiretroviral therapy for HIV disease . N Engl J Med. . 2001;344:824–831
  15. Freedberg KA , Scharfstein JA , Seage GR , et al.   The cost-effectiveness of preventing AIDS-related opportunistic infections . JAMA. . 1998;279:130–136
  16. Weinstein MC , Goldie SJ , Losina E , et al.   Use of genotypic resistance testing to guide HIV therapy (clinical impact and cost-effectiveness) . Ann Intern Med. . 2001;134:440–450
  17. Multicenter AIDS Cohort Study (MACS) Public Dataset (Release PO4) . Springfield, Virginia: National Technical Information Service; 1995;
  18. Enger C , Graham N , Peng Y , et al.   Survival from early, intermediate, and late stages of HIV infection . JAMA. . 1996;275:1329–1334
  19. Mellors JW , Munoz A , Giorgi JV , et al.   Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection . Ann Intern Med. . 1997;126:946–954
  20. Samet JH , Freedberg KA , Savetsky JB , Sullivan LM , Stein MD . Understanding delay to medical care for HIV infection (the long-term non-presenter) . AIDS. . 2001;15:77–85
  21. The Panel on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services (DHHS) and the Henry J. Kaiser Family Foundation . Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents . 2003; November 10, Available at http://aidsinfo.nih.gov
  22. Carcelain G , Blanc C , Leibowitch J , et al.   T cell changes after combined nucleoside analogue therapy in HIV primary infection . AIDS. . 1999;13:1077–1081
  23. Kaufmann GR , Zaunders JJ , Cunningham P , et al.   Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection . AIDS. . 2000;14:2643–2651
  24. Malhotra U , Berrey MM , Huang Y , et al.   Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection . J Infect Dis. . 2000;181:121–131
  25. Walensky RP , Goldie SJ , Sax PE , et al.   Treatment for primary HIV infection (projecting outcomes of immediate, interrupted, or delayed therapy) . J Acquir Immune Defic Syndr. . 2002;31:27–37
  26. Dybul M , Bolan R , Condoluci D , et al.   Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings . J Infect Dis. . 2002;185:1818–1821
  27. Sackoff JE , Shin SS . Trends in immunologic and clinical status of newly diagnosed HIV-positive patients initiating care in the HAART era . J Acquir Immune Defic Syndr. . 2001;28:270–272
  28. Roome A , Hadler J , Birkhead G , et al.   HIV testing among pregnant women—United States and Canada, 1998–2001 . MMWR Morb Mortal Wkly Rep. . 2002;51:1013–1016
  29. Walensky RP , Losina E , Skolnik PR , et al.   Voluntary HIV testing as part of routine medical care—Massachusetts, 2002 . MMWR Morb Mortal Wkly Rep. . 2004;53:523–526
  30. Stringer EM , Stringer JS , Cliver SP , Goldenberg RL , Goepfert AR . Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates . MMWR Morb Mortal Wkly Rep. . 2001;50:1054–1058
  31. Update (HIV counseling and testing using rapid tests—United States, 1995) . MMWR Morb Mortal Wkly Rep. . 1998;47:211–215
  32. CDC . HIV Counseling and Testing in Publicly Funded Sites (1995 Summary Report) . Atlanta, Georgia: U.S. Department of Health and Human Services; 1997;
  33. Moore M , Gerber AR , Campbell CH , Dillon BA , West GR , Valdiserri RO . A study of clients returning for counseling after HIV testing (implications for improving rates of return) . Pub Health Rep. . 1993;108:12–18
  34. Bell RA , Truax SR , Ruiz JD , Sun RK , Molitor F . Predictors of failure to return for HIV test result and counseling by test site type . AIDS Educ Prev. . 1999;11:1–13
  35. Staszewski S , Morales-Ramirez J , Tashima KT , et al.   Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team . N Engl J Med. . 1999;341:1865–1873
  36. Hammer SM , Squires KE , Hughes MD , et al.  AIDS Clinical Trials Group 320 Study Team   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less . N Engl J Med. . 1997;337:725–733
  37. Baxter JD , Mayers DL , Wentworth DN , et al.  CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS   A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy . AIDS. . 2000;14:F83–F93
  38. Mylonakis E . Laboratory testing for infection with the human immunodeficiency virus (established and novel approaches) . Am J Med. . 2000;109:568–576
  39. Varghese B , Peterman TA , Holtgrave DR . Cost-effectiveness of counseling and testing and partner notification (a decision analysis) . AIDS. . 1999;13:1745–1751
  40. Farnham PG , Gorsky RD , Holtgrave DR , Jones WK , Guinan ME . Counseling and testing for HIV prevention (costs, effects, and cost-effectiveness of more rapid screening tests) . Public Health Rep. . 1996;111:44–53
  41. Ekwueme DU , Pinkerton SD , Holtgrave DR , Branson BM . Cost comparison of three HIV counseling and testing technologies . Am J Prev Med. . 2003;25:112–121
  42. Drug Topics Red Book . Montvale, New Jersey: Medical Economics; 2001;
  43. Health Care Financing Administration (HCFA) of the Department of Health and Human Services (DHHS) . Clinical Diagnostic Laboratory Fee Schedule (CLAB) . 2001; Available at: www.cms.hhs.gov/providers/pufdownload/default.asp#labfree Accessed September 22, 2003
  44. Kaplan JE , Masur H , Holmes KK  Public Health Service and the Infectious Diseases Society of America . Guidelines for preventing opportunistic infections among HIV-infected persons—2002. Recommendations of the U.S . MMWR Recomm Rep. . 2002;51:1–52
  45. Statistical Abstract of the United States (1998) . 118th ed.. Washington, D.C: Bureau of the Census; 1998;
  46. Statistics for U.S. Hospital Stays, Diagnosis Related Groups (DRGs), Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS). Agency for Healthcare Research and Quality. Rockville, Maryland. Available at: http://hcup.ahrq.gov/HCUPnet.aspAccessed December 23, 2003
  47. Daar ES , Little S , Pitt J , et al.  Los Angeles County Primary HIV Infection Recruitment Network   Diagnosis of primary HIV-1 infection . Ann Intern Med. . 2001;134:25–29
  48. Hecht FM , Busch MP , Rawal B , et al.   Use of laboratory tests and clinical symptoms for identification of primary HIV infection . AIDS. . 2002;16:1119–1129
  49. AIDS Cost and Services Utilization Survey (Public Use Tapes 4 and 5. No. PB94189891) . Springfield, Virginia: National Technical Information Service; 1994;
  50. Finkler SA . The distinction between cost and charges . Ann Intern Med. . 1982;96:102–109
  51. Gold MR , Siegel JE , Russell LB , Weinstein MC . Cost Effectiveness in Health and Medicine . New York, New York: Oxford University Press; 1996;
  52. Palella FJ , Delaney KM , Moorman AC , et al.   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection . N Engl J Med. . 1998;338:853–860
  53. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults . MMWR Recomm Rep. . 1992;41:961–962
  54. CDC . HIV/AIDS . Surv Rep. . 1999;11:1–44
  55. Immergluck LC , Cull WL , Schwartz A , Elstein AS . Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago . Pediatrics. . 2000;105:E54
  56. McKay NL , Phillips KM . An economic evaluation of mandatory premarital testing for HIV . Inquiry. . 1991;28:236–248
  57. Owens DK , Nease RF , Harris RA . Cost-effectiveness of HIV screening in acute care settings . Arch Intern Med. . 1996;156:394–404
  58. Lurie P , Avins AL , Phillips KA , Kahn JG , Lowe RA , Ciccarone D . The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection . JAMA. . 1994;272:1832–1838
  59. The cost-effectiveness of screening for type 2 diabetes . CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention . JAMA. . 1998;280:1757–1763
  60. Littenberg B , Garber AM , Sox HC . Screening for hypertension . Ann Intern Med. . 1990;112:192–202
  61. Frazier AL , Colditz GA , Fuchs CS , Kuntz KM . Cost-effectiveness of screening for colorectal cancer in the general population . JAMA. . 2000;284:1954–1961
  62. U.S. Preventive Services Task Force (Guide to Clinical Preventive Services) . 2nd ed.. Baltimore, Maryland: Williams and Wilkins; 1996;
  63. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group . The NIMH Multisite HIV Prevention Trial (reducing HIV sexual risk behavior) . Science. . 1998;280:1889–1894
  64. Kamb ML , Fishbein M , Douglas JM , et al.  Project RESPECT Study Group   Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases (a randomized controlled trial) . JAMA. . 1998;280:1161–1167
  65. Gibson D . Effectiveness of brief counseling in reducing HIV risk behavior in injecting drug users (final results of randomized trials of counseling with and without HIV testing) . AIDS Behav. . 1999;3:3–12
  66. Morrison AS . Screening in Chronic Disease . 2nd ed.. New York, New York: Oxford University Press; 1992;
  67. In: Cancer Facts and Figures, 2002 . Vol. 2003: Atlanta, Georgia: American Cancer Society; 2002;
  68. Advancing HIV prevention (new strategies for a changing epidemic—United States, 2003) . MMWR Morb Mortal Wkly Rep. . 2003;52:329–332

 This research was funded by the National Institute of Allergy and Infectious Diseases (K23AI01794, K24AI062476, K25AI50436, R01AI42006, Center for AIDS Research P30AI42851), the National Institute of Mental Health (R01MH65869), the National Institute on Drug Abuse (R01DA015612), and the Centers for Disease Control and Prevention (S1396-20/21).

PII: S0002-9343(04)00746-6

doi: 10.1016/j.amjmed.2004.07.055

The American Journal of Medicine
Volume 118, Issue 3 , Pages 292-300 , March 2005

Article Tools

* Image Usage & Resolution